MYDA Advisors’s LianBio American Depositary Shares LIAN Stock Holding History

MYDA Advisors’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$447K	–	148
2023 Q4	$447K	Sell	100,000 -100,000	-50%	-$344K	0.15%	68
2023 Q3	$298K	Buy	200,000 +62,149	+45%	+$118K	0.1%	88
2023 Q2	$314K	Buy	137,851 +17,851	+15%	+$41K	0.09%	93
2023 Q1	$235K	Sell	120,000 -15,000	-11%	-$31.1K	0.09%	97
2022 Q4	$221K	Buy	135,000 +15,000	+13%	+$23.4K	0.14%	70
2022 Q3	$240K	Hold	120,000	–	–	0.11%	113
2022 Q2	$259K	Buy	120,000 +34,000	+40%	+$115K	0.07%	151
2022 Q1	$319K	Buy	86,000 +66,000	+330%	+$273K	0.13%	137
2021 Q4	$123K	Buy	+20,000	New	+$228K	0.03%	211

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

MYDA Advisors's LIAN Position: Q1 2024 in Review

MYDA Advisors sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 100,000 shares — an estimated $447K sold.

MYDA Advisors first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $447K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

MYDA Advisors reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
MYDA Advisors sold 100,000 LianBio American Depositary Shares shares in Q1 2024, an estimated $447K.
MYDA Advisors first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
MYDA Advisors's LianBio American Depositary Shares position peaked at $447K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on MYDA Advisors's 13F filing for Q1 2024, filed 14 May 2024.